a second vaccine for young people could be approved before the start of the school year – .

0
14
a second vaccine for young people could be approved before the start of the school year – .


WINNIPEG – A second vaccine for 12 to 17 year olds could be approved in Canada before the start of the school year.

According to health officials, the decision to give Moderna to people in this age group could be made by mid-July. Currently, only Pfizer is approved for persons 12 to 17 years of age in Canada.

“Health Canada has adjusted its overall timeline estimates for a decision on Moderna approval for 12 to 17 year olds,” said Dr. Joss Reimer, medical lead for the Manitoba Vaccine Implementation Working Group, at a press conference on Wednesday.

“They originally thought it would be the end of June, they are now speaking mid-July for a decision. Of course, they didn’t give us an exact date. We’ll have to wait and see what they decide eventually.

For those under 12, Moderna and Pfizer both undergo vaccine efficacy trials for six months up to 11 years.

Reimer said they expected the first results, which will likely affect people between the ages of five and 11, could be released in September. The companies would then have to get approval from Health Canada.

“There are still many different factors that could adjust these times,” she said.

“So that’s kind of our planning assumption on our side right now, is that it’s possible that we could see some approvals until the age of five in September, but it’s very beyond our control and even beyond the control of Health Canada, as companies are still working on these trials as we speak.

LEAVE A REPLY

Please enter your comment!
Please enter your name here